Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score AnalysisFélix Ackermann, Marie-Laure Chabi, Thierry Chinet et al.|Journal of Clinical Immunology|2020Cited by 53
The ID NOW COVID-19, a high-speed high-performance assayÉric Farfour, C Amiel, Marianne Asso‐Bonnet et al.|European Journal of Clinical Microbiology & Infectious Diseases|2021Cited by 16
COVID-19: before stopping specific infection prevention and control measures, be sure to exclude the diagnosisÉric Farfour, Philippe Lesprit, M-C. Ballester et al.|Journal of Hospital Infection|2020Cited by 6
Tocilizumab to Prevent Ventilatory Support for Severe Worsening COVID-19 Pneumonia: A Propensity Score AnalysisMathilde Roumier, Félix Ackermann, Romain Paule et al.|SSRN Electronic Journal|2020Cited by 1